Keyphrases
Bilirubin
30%
Glycogen Storage Disease
28%
Gunn Rat
25%
Free Bilirubin
21%
Fanconi-Bickel Syndrome
19%
Human Serum Albumin
17%
Bilirubin Level
17%
Total Bilirubin
17%
Albumin
17%
Phototherapy
17%
Brainstem Auditory Evoked Potentials
17%
Brainstem Dysfunction
17%
Preterm Infants
17%
Albumin Administration
17%
Neonatal Hyperbilirubinemia
17%
Ursodeoxycholic Acid
17%
Bile Acids
17%
Des-gamma-carboxy Prothrombin
17%
Continuous Glucose Monitoring
17%
Monitoring Metrics
17%
Liver Glycogen
17%
Ketotic Hypoglycemia
17%
Retrospective Observational Study
17%
Single Center
17%
Urinary Excretion
17%
Dietary Polysaccharides
17%
Polysaccharide
17%
Glucose Production
17%
Ex Vivo Model
17%
Precision-cut Liver Slices
17%
Hepatic Glucose Production
17%
Neonatal Jaundice
14%
Crigler-Najjar
10%
Farnesoid X Receptor
10%
Healthy Individuals
9%
Gestational Age
7%
Neurotoxicity
7%
Birth Weight
7%
Risk Factors
7%
Bilirubin Binding
7%
Hepatic Glycogen Storage Disease
7%
Glycogen Content
7%
Lean Body Mass
7%
Inborn Errors of Metabolism
7%
Conjugating Enzyme
5%
Phenylhydrazine
5%
Feeding Interval
5%
Hyperbilirubinemia
5%
Medicine and Dentistry
Glycogen Storage Disease
44%
Hypoglycemia
37%
Bilirubin
33%
Hepatocellular Carcinoma
26%
Disease
23%
Hyperbilirubinemia
22%
Exchange Blood Transfusion
21%
Inflammatory Bowel Disease
17%
Endoscopy
17%
Hyperlactatemia
17%
Bile Acid
17%
Glycogen Storage Disease Type I
17%
Newborn Screening
17%
Patient Referral
17%
Neonatal Hyperbilirubinemia
17%
Water-Electrolyte Imbalance
17%
Gluconeogenesis
17%
Hepatomegaly
17%
Ursodeoxycholic Acid
17%
Hypertriglyceridemia
17%
Des-Gamma Carboxyprothrombin
17%
Sodium Glucose Cotransporter 2 Inhibitor
17%
Kidney Tubule Disorder
17%
Empagliflozin
17%
Observational Study
17%
Phototherapy
13%
Farnesoid X Receptor
10%
Tumor Marker
10%
Faecal Calprotectin
9%
Clinical Feature
8%
Neutropenia
8%
Sequela
8%
Glycogenolysis
8%
Infancy
8%
Liver Adenoma
8%
Acute Disease
8%
Neutrophil
8%
Infant Feeding
8%
Nephropathy
8%
Glucose 6 Phosphate
8%
Physical Disease by Body Function
8%
Gestational Age
6%
Pediatrics
5%
Birth Weight
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bilirubin
100%
Gunn Rat
60%
Neonatal Hyperbilirubinemia
35%
Glycogen Storage Disease
35%
Hyperbilirubinemia
34%
Neurotoxicity
31%
Human Serum Albumin
24%
Hypoglycemia
20%
Syndrome
19%
Mouse Model
17%
Bile Acid
17%
Ursodeoxycholic Acid
17%
Decarboxyprothrombin
17%
Kidney Tubule Disorder
17%
Repurposing
17%
Empagliflozin
17%
Liver Cell Carcinoma
17%
Sodium Glucose Cotransporter 2 Inhibitor
17%
Observational Study
17%
Newborn Jaundice
11%
Farnesoid X Receptor
10%
Tumor Marker
10%
Crigler Najjar Syndrome
7%
Receptor Agonist
7%
Mouse
7%
Epileptic Absence
6%
Kernicterus
5%
Sulfadimethoxine
5%
